The use of tissue adhesive in management of genitourinary fistulas: a systematic review and case report
- PMID: 35947188
- DOI: 10.1007/s00192-022-05297-0
The use of tissue adhesive in management of genitourinary fistulas: a systematic review and case report
Abstract
Introduction and hypothesis: Articles are getting published on the use of tissue adhesive for vesicovaginal fistula. The objective is to carry out a systematic review on their effectiveness and complications.
Methods: A systematic review of the literature was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Two reviewers screened abstracts and full-text and extracted data independently. A narrative synthesis was conducted given the heterogeneity of studies.
Results: A total of 1032 studies were identified after searching the database, and 14 articles were included in this systematic review. Of the 84 women included, 12 (14.3%) presented failure or recurrence of their fistula tract. The mean time of follow-up was 11.46 months. The average size of the fistula was 1.05 (range 0.1 to 3.9) cm. Most fistulas (81) included were vesicovaginal fistulas. Nine papers reported the usage of fibrin glue in which only three (6.5%) women reported recurrence of the fistula in a delay of 2 weeks to 26 months. The other studies used cyanoacrylate (14 women) and autologous fibrin injection from the patients' blood (31 women). No significant complications were reported. Complications reported were urinary tract infections in 3 women (3.6%), hematuria in 2 women (2.4%), overactive bladder symptoms in 6 women (7.2%) and septic pelvic thrombosis in one woman (1.2%).
Conclusions: Tissue adhesive appears to be a promising alternative for management of urogenital fistulas without reported important complications.
Keywords: Cyanoacrylate; Fibrin glue; Fistula; Tissue adhesive; Tissue sealant; Vesicovaginal fistula.
© 2022. The International Urogynecological Association.
Similar articles
-
Endoscopic injection of fibrin glue for the treatment of urinary-tract pathology.J Endourol. 2005 Apr;19(3):419-23. doi: 10.1089/end.2005.19.419. J Endourol. 2005. PMID: 15865540
-
Vesicovaginal fistula treated with fibrin glue.Int J Gynaecol Obstet. 2001 May;73(2):147-9. doi: 10.1016/s0020-7292(00)00381-7. Int J Gynaecol Obstet. 2001. PMID: 11336734
-
A novel method for iatrogenic vesicovaginal fistula treatment: autologous platelet rich plasma injection and platelet rich fibrin glue interposition.J Urol. 2013 Jun;189(6):2125-9. doi: 10.1016/j.juro.2012.12.064. Epub 2012 Dec 28. J Urol. 2013. PMID: 23276515
-
Repair of Vesicovaginal Fistulae: A Systematic Review.Obstet Gynecol. 2024 Feb 1;143(2):229-241. doi: 10.1097/AOG.0000000000005468. Epub 2023 Nov 30. Obstet Gynecol. 2024. PMID: 38033311 Free PMC article.
-
Endoscopic management of leaks and fistulas after bariatric surgery: a systematic review and meta-analysis.Surg Endosc. 2021 Mar;35(3):1067-1087. doi: 10.1007/s00464-020-07471-1. Epub 2020 Feb 27. Surg Endosc. 2021. PMID: 32107632 Free PMC article.
References
-
- Raji MO, Raji IA, Hassan M, Raji HO, Bashir AM, Suleiman IN, Abubakar HU. Assessment of health-related quality of life of vesicovaginal fistula patients attending a repair center in Northwest Nigeria. Ann Afr Med. 2021;20(2):132–7.
-
- Ayed M, El Atat R, Hassine LB, Sfaxi M, Chebil M, Zmerli S. Prognostic factors of recurrence after vesicovaginal fistula repair. Int J Urol. 2006;13(4):345–9. - DOI
-
- Paul Abrams, Linda Cardozo, Adrian Wagg, Alan Wein. Incontinence 6th edition. Chapter 18 Fistula. 2017. 2143-2184
-
- Sinha S, Naik M, Wright V, Timmons J, Campbell AC. A single blind, prospective, randomized trial comparing n-butyl 2-cyanoacrylate tissue adhesive (Indermil) and sutures for skin closure in hand surgery. J Hand Surg Br. 2001;26(3):264–5. - DOI
-
- Reece TB, Maxey TS, Kron IL. A prospectus on tissue adhesives. Am J Surg. 2001;182(2 Suppl):40S. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources